Key terms

About BTMD

biote Corp. is a woman-led company, which engages in providing bio identical hormone pellet therapy. It delivers a comprehensive, end-to-end platform that provides practitioners with medical education, training and certification, practice management software, and digital and point-of-care marketing support. The company is headquartered in Irving, TX.

Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
     
52-week range
     
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date

Key terms

Smart score

Latest BTMD news

May 07 4:50pm ET Biote affirms FY24 revenue view of $200M-$204M, consensus $202.3M May 07 4:49pm ET Biote reports Q1 EPS (6c), consensus 3c Apr 29 4:32pm ET Biote Settles Litigation and Repurchases Shares from Founder Apr 29 4:19pm ET Biote enters into settlement with founder Gary Donovitz Apr 04 4:55am ET Biote management to meet with B. Riley Mar 28 3:44pm ET Biote management to meet with B. Riley Mar 14 9:15pm ET Optimistic Outlook: Biote’s Growth Potential and Strategic Initiatives Despite Transitional Challenges Mar 14 4:24pm ET Biote Corp. Releases March 2024 Investor Presentation Mar 13 7:49am ET Biote price target raised to $9 from $8 at Roth MKM Mar 13 7:40am ET Analysts Are Bullish on Top Healthcare Stocks: biote (BTMD), Incyte (INCY) Mar 12 4:09pm ET Biote sees FY24 revenue $200M-$204M, consensus $203.17M Mar 12 4:08pm ET Biote reports Q4 EPS 18c, consensus 8c Feb 27 7:48am ET Truist Financial Issues a Buy Rating on biote (BTMD) Feb 20 9:15pm ET Buy Rating on Biote’s Stock: A Positive Outlook Amidst Nutraceutical Challenges Feb 20 4:35pm ET Biote Corp. Settles Litigation and Repurchases Founder’s Shares Feb 20 8:50am ET B. Riley starts Biote with Buy on horome replacement therapy potential Feb 20 8:50am ET B. Riley starts Biote with Buy on horome replacement therapy potential Feb 20 5:41am ET Biote initiated with a Buy at B. Riley

No recent press releases are available for BTMD

BTMD Financials

1-year income & revenue

Key terms

BTMD Forecasts

analyst rating

  • buy
  • hold
  • sell

We're sorry, but this
information is
temporarily unavailable.

1-year stock price forecast

BTMD Competitors

$ Market cap P/E ratio $ Price 1d change 52-week range

Key terms